| Recent developments of hydrazide/hydrazone derivatives and their analogs as anticonvulsant agents in animal models V Angelova, V Karabeliov, PA Andreeva‐Gateva, J Tchekalarova Drug development research 77 (7), 379-392, 2016 | 103 | 2016 |
| Oxidative stress and aging as risk factors for Alzheimer’s disease and Parkinson’s disease: the role of the antioxidant melatonin J Tchekalarova, R Tzoneva International journal of molecular sciences 24 (3), 3022, 2023 | 101 | 2023 |
| Effect of long-term caffeine administration on depressive-like behavior in rats exposed to chronic unpredictable stress DM Pechlivanova, JD Tchekalarova, LH Alova, VV Petkov, RP Nikolov, ... Behavioural pharmacology 23 (4), 339-347, 2012 | 81 | 2012 |
| Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light J Tchekalarova, T Stoynova, K Ilieva, R Mitreva, M Atanasova Pharmacology biochemistry and behavior 171, 1-9, 2018 | 80 | 2018 |
| Dose-dependent effects of caffeine on behavior and thermoregulation in a chronic unpredictable stress model of depression in rats D Pechlivanova, J Tchekalarova, R Nikolov, K Yakimova Behavioural brain research 209 (2), 205-211, 2010 | 72 | 2010 |
| Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility? J Tchekalarova, V Georgiev Life sciences 76 (9), 955-970, 2005 | 72 | 2005 |
| Prophylactic treatment with melatonin after status epilepticus: Effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy J Tchekalarova, Z Petkova, D Pechlivanova, S Moyanova, L Kortenska, ... Epilepsy & Behavior 27 (1), 174-187, 2013 | 70 | 2013 |
| Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy JD Tchekalarova, NM Ivanova, DM Pechlivanova, D Atanasova, ... Pharmacology Biochemistry and Behavior 127, 27-36, 2014 | 61 | 2014 |
| Diurnal variations in depression-like behavior of Wistar and spontaneously hypertensive rats in the kainate model of temporal lobe epilepsy J Tchekalarova, D Pechlivanova, T Atanasova, P Markova, V Lozanov, ... Epilepsy & Behavior 20 (2), 277-285, 2011 | 60 | 2011 |
| Long-term treatment with losartan attenuates seizure activity and neuronal damage without affecting behavioral changes in a model of co-morbid hypertension and epilepsy JD Tchekalarova, N Ivanova, D Atanasova, DM Pechlivanova, N Lazarov, ... Cellular and molecular neurobiology 36 (6), 927-941, 2016 | 57 | 2016 |
| Treatment with melatonin after status epilepticus attenuates seizure activity and neuronal damage but does not prevent the disturbance in diurnal rhythms and behavioral … Z Petkova, J Tchekalarova, D Pechlivanova, S Moyanova, L Kortenska, ... Epilepsy & Behavior 31, 198-208, 2014 | 56 | 2014 |
| Diurnal rhythms of spontaneous recurrent seizures and behavioral alterations of Wistar and spontaneously hypertensive rats in the kainate model of epilepsy J Tchekalarova, D Pechlivanova, D Itzev, N Lazarov, P Markova, ... Epilepsy & Behavior 17 (1), 23-32, 2010 | 55 | 2010 |
| Postnatal caffeine exposure: effects on motor skills and locomotor activity during ontogenesis J Tchekalarova, H Kubova, P Mareš Behavioural brain research 160 (1), 99-106, 2005 | 55 | 2005 |
| Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice J Tchekalarova, K da Conceição Machado, ALG Júnior, ... Seizure 57, 22-26, 2018 | 50 | 2018 |
| Consequences of long-term treatment with agomelatine on depressive-like behavior and neurobiological abnormalities in pinealectomized rats J Tchekalarova, Z Nenchovska, D Atanasova, M Atanasova, L Kortenska, ... Behavioural brain research 302, 11-28, 2016 | 47 | 2016 |
| Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy J Tchekalarova, D Atanasova, Z Nenchovska, M Atanasova, L Kortenska, ... Neurobiology of Disease 104, 1-14, 2017 | 41 | 2017 |
| Discovery of novel indole-based aroylhydrazones as anticonvulsants: Pharmacophore-based design VT Angelova, M Rangelov, N Todorova, M Dangalov, P Andreeva-Gateva, ... Bioorganic Chemistry 90, 103028, 2019 | 39 | 2019 |
| Up-regulation of adenosine A1 receptor binding in pentylenetetrazol kindling in mice: effects of angiotensin IV J Tchekalarova, E Sotiriou, V Georgiev, G Kostopoulos, F Angelatou Brain research 1032 (1-2), 94-103, 2005 | 38 | 2005 |
| Effects of AT1 receptor antagonism on kainate-induced seizures and concomitant changes in hippocampal extracellular noradrenaline, serotonin, and dopamine levels in Wistar … J Tchekalarova, E Loyens, I Smolders Epilepsy & Behavior 46, 66-71, 2015 | 35 | 2015 |
| Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels J Tchekalarova, D Albrecht Neuroscience letters 415 (1), 68-72, 2007 | 35 | 2007 |
Alexander StoynevProfessor of Pathophysiology, Dept. PathophysiologyVerified email at medfac.acad.bg
